Active teams
A new antibody technology tailored for killing of antibiotic-resistant bacteria and cancer cells
- Project leader: Mirjam Dürkoop, The Laboratory of Adaptive Immunity and Homeostasis, Centre of Excellence, Precision Immunotherapy Alliance (PRIMA), Department for Pharmacology, University of Oslo and Department for Immunology, Oslo University Hospital
- Team members: Professor Jan Terje Andersen, Stian Foss, Peter Skorpil (Inven2) and Kirsten Stangebye (Inven2)
Nexus - Transforming Patient Care with a Novel Endoscopic Stent Solution
- Project leader: Magnus Løberg, Faculty of Medicine, University of Oslo
- Team member: Christer Julseth Tønnesen
Finalization and Testing of an Integrated Illumination Lightguide Prototype for Cryo-Retinal Surgery
- Project leader: Goran Petrovski, Department of Ophthalmology and Center for Eye Research and Innovative Diagnostics, University of Oslo and Oslo University Hospital
- Team members: Eirik Albert Torheim, Inven2
BePREPAReD: Bedside PREvention of critical illness in Preterm infants using Artificial intelligence and eNose Devices
- Project leader: Åsbjørn Schumacher Westvik, Department of Neonatal Intensive Care, Oslo University Hospital and Faculty of Medicine, University of Oslo
- Team members: Dr. Sissel Jennifer Moltu (PI, Oslo University Hospital), Prof. Oliver Tomic (Machine Learning & Chemometrics, NMBU), Dr. Alexander Rowe (Bioinformatics, Oslo University Hospital), Prof. Charlotte Tscherning (Neonatologist, University of Oslo)
Resolving bacterial infections
- Project leader: Professor Trond Vidar Hansen, Department of Pharmacy, University of Oslo
- Team members: Associate professor Osman Gani Dept. of Pharmacy), Post. Doctoral-Fellow Dr. Amalie F. Reinertsen (Dept. of Pharmacy), PhD-student Daniel H. Hasselstrøm (Dept. of Pharmacy) and Beate Rygg Johnsen (UiO Growth House).
Drug discovery for assisted amyloid beta peptide clearance
- Project leader: Tormod Fladby, Department of Neurology, Akershus University Hospital (Ahus)
- Team members: Marianne Wettergren (Senior biotechnician, Ahus), Berglind Gisladottir (Senior biotechnician, Ahus), Bjørn-Eivind Kirsebom (Biostatistician, University Hospital of Northern Norway), Peter Mikael Arnesen (Bioinformatician, Ahus) and Panpan You (Researcher, Ahus)
ProClass – A patient-specific molecular classifier independent of heterogeneity in primary prostate cancer
- Project leader: Bjarne Johannessen, Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital
- Team members: Rolf I. Skotheim, Karol Axcrona, Ragnhild A. Lothe, Ulrika Axcrona, Tor Åge Myklebust, Susanne G. Kidd, Anne Cathrine Bakken, Lise Rødsten
Wearable Electrophysiology Mobility Solutions in Parkinson’s Disease [WEBSPD]
- Project leader: Tarun Arora, Researcher, Department of Neurology, Oslo University Hospital
- Team members: Mathias Toft (UiO), Christian Tronstad (OUH), Kristian Bernhard Nilsen (OUH), Lasse Pihlstrøm (OUH)
Small molecules targeting FoxP3+ Regulatory T cells for cancer immunotherapy
- Project leader: Qian Wei, Postdoctoral researcher, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital
- Team members: Professor Kjetil Taskén (UiO/OUH), Professor Rafi Ahmad (INN University), Postdoc Nuria García-Díaz (OUH) and UiO Growth House
Restoring metabolic balance – therapy for Maple Syrup Urine Disease
- Project leader: Bjørn Dalhus, Researcher, Department for Medical Biochemistry, Institute of Clinical Medicine, University of Oslo
- Team members: Professor Lars Eide, Department for Medical Biochemistry, UiO, Pernille Blicher, UiO and Marte Eikenes, UiO
Advanced Technology for Identifying and Detecting RNA Modification-Based Cancer Markers
- Project leader: Yanjiao Li, Postdoctoral researcher, Oslo University Hospital
- Team members: Arne Klungland, Professor and Director CRESCO - Centre for Embryology and Healthy Development, Institute of Clinical Medicine, University of Oslo
Autologous cell-based therapy for coagulation factor deficiency
- Project leader: Giacomo Roman, Department of Haematology, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital
- Team members: Maria E. Chollet (UiO/OUS), Anindita Bhattacharya (UiO/OUS), Knut Lauritzen (UiO/OUS), Christian Qvigstad (UiO/OUS), Gareth Sullivan (OUS), Per Morten Sandset (UiO/OUS), Benedicte Stavik (OUS)
Blood-based test for solid cancer early detection
- Project leader: Carmen Herrera, Section for Biochemistry and Molecular Biology, Department of Biosciences, University of Oslo
- Team members: Pål Falnes (UiO) and UiO Growth House
Ligament balancing in total knee arthroplasty - a systematic approach to Bellemans technique
- Project leader: Lars Engseth, Department of Orthopaedics - Ullevål, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital
- Team members: Stephan Röhrl (OUS/UiO), Jørgen Grønsund (UiS/Moreld Capnor)
EvoMab: germinal center guided affinity maturation of therapeutic antibodies
- Project leader: Johanne Jacobsen, Department of Immunology, Institute of Clinical Medicine, University of Oslo
- Team member: Valgerdur Bjørnsdottir (UiO)
Mathematical biomarkers for personalized cancer medicine
- Project leader: Alvaro Köhn-Luque, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo and Department of Medical Genetics, Oslo University Hospital
- Team members: Arnoldo Frigessi (UiO/OUS), Aleix Prat (Hospital Clinic Barcelona), Fara Brasó-Maristany (Hospital Clinic Barcelona), Vessela Kristensen (OUS/UiO), Leonard Schmiester (OUS)
PharmaChip
- Project leader:Steven Ray Wilson, Section for Chemical Life Sciences - Biomolecules, Bio-inspired Materials and Bioanalytics, University of Oslo
- Team members: Frøydis Sved Skottvoll (SINTEF), Aleksandra Aizenshtadt (UiO), Stefan Krauss (UiO/OUS), Stig Pedersen-Bjergaard (UiO), Michal Mielnik (SINTEF)
Development of engineered NK-EVs for Targeted Therapy in Breast Cancer
- Project leader: Marit Inngjerdingen, Dept. of Pharmacology, Institute of Clinical Medicine, Faculty of Medicine, UiO
- Team members: Amanda Sudworth (UiO) and Jørgen Wesche (OUS/UiO)
Personalized Rapid Ex vivo Determination of Immunotherapeutic Cancer Treatment (PREDICT)
- Project leader: Audun Kvalvaag, Institute for Cancer Research, Oslo University Hospital
- Team members: Dr. Ieva Ailte (OUS) and Professor Harald Stenmark (OUS/UiO)